Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Weinhage, , Stephen,
DOB: 11-AUG-1950 (Age: 75)
Gender: male
Address:
Bertold-Stahr-Platz 6/3
31535 Neustadt am Rübenberge (Germany)
ID: 6413-101438-9 (ECI)
Report
Date: 15-MAY-2023
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Landarztpraxis Dudensen
Dudenser Straße 41A
31535 Neustadt am Rübenberge (Germany)
Specimen
Collected: 15-MAY-2023

Chemistry

Test 15-MAY-2023 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.9 H 4.8 - 5.7 %
Cholesterol [Mass/volume] in Serum or Plasma 247.8 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 285.9 H 40 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 174.4 0 - 190 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 56.2 40 - 60 mg/dL
Glucose [Mass/volume] in Blood 108.1 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 18.7 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 2.8 H 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.4 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 142.9 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.2 H 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 106.0 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 25.5 22 - 32 mmol/L
Protein [Mass/volume] in Serum or Plasma 7.4 6.6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 4.1 3.5 - 5.5 g/dL
Globulin [Mass/volume] in Serum by calculation 3.0 2 - 3.5 g/L
Bilirubin.total [Mass/volume] in Serum or Plasma 0.3 0.3 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 57.1 53 - 130 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 46.9 7 - 60 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 33.1 10 - 49 U/L
Glucose [Mass/volume] in Blood 108.1 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 18.7 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.8 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.4 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 142.9 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.2 H 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 106.0 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 25.5 22 - 32 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 213.3 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 160.7 H 40 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 133.5 0 - 190 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 47.7 40 - 60 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 2.7 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows poor glycemic control (HbA1c 6.9%) and dyslipidemia (elevated cholesterol and triglycerides), increasing cardiovascular risk. Mildly elevated creatinine and potassium may indicate early renal impairment, but urine microalbumin/creatinine is normal. Liver function and electrolytes are within normal limits. Recommend clinical correlation for diabetes and renal function management, and consider lipid-lowering therapy.